Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Vet Med Sci ; 85(10): 1047-1051, 2023 Oct 17.
Artigo em Inglês | MEDLINE | ID: mdl-37587049

RESUMO

A 1-year-old spayed female Miniature Schnauzer had chronic hyponatremia, accompanied by polyuria and polydipsia. Blood tests and urinalysis revealed severe hyponatremia, low plasma osmolality with euvolemia, and increased sodium excretion in urine. Hypothyroidism and hypoadrenocorticism were ruled out as causes. These findings led to the diagnosis of syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Magnetic resonance imaging (MRI) showed dilation of the lateral ventricles, indicating severe hydrocephalus. Tolvaptan, a vasopressin V2 receptor antagonist commonly used in human SIADH, was administered along with water restriction. This treatment resulted in a consistent increase in plasma sodium levels without any adverse effects. This case report represents the first documented evidence of the therapeutic efficacy of tolvaptan in treating SIADH in a dog.


Assuntos
Doenças do Cão , Hiponatremia , Síndrome de Secreção Inadequada de HAD , Cães , Feminino , Humanos , Animais , Tolvaptan/uso terapêutico , Hiponatremia/tratamento farmacológico , Hiponatremia/etiologia , Hiponatremia/veterinária , Síndrome de Secreção Inadequada de HAD/complicações , Síndrome de Secreção Inadequada de HAD/tratamento farmacológico , Síndrome de Secreção Inadequada de HAD/veterinária , Antagonistas dos Receptores de Hormônios Antidiuréticos/uso terapêutico , Vasopressinas/uso terapêutico , Sódio , Benzazepinas/uso terapêutico , Doenças do Cão/tratamento farmacológico
2.
In Vivo ; 36(2): 764-772, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35241532

RESUMO

BACKGROUND/AIM: Chimeric antigen receptor (CAR) T cell therapy targeting CD20 has the potential to become a promising novel treatment for canine B cell lymphoid malignancy. However, the optimal approach for producing potent CAR-T cells with favorable phenotype for dogs remains unknown. In this study, we assessed several culture conditions and their effects on the phenotypic characteristics of CD20-CAR-T cells. MATERIALS AND METHODS: Canine CAR-T cells were generated by incubating with several mitogens in the presence or absence of Akt inhibitor. Gene transduction efficiency and phenotypic characteristics were determined by flow cytometry. RESULTS: Comparison of several kinds of mitogens revealed that stimulation with phytohemagglutinin has high transduction efficacy, whereas stimulation with concanavalin A was superior in memory T cell formation. Akt inhibition at the initial stage of CAR-T production tended to enhance transduction efficiency and memory T cell formation. CONCLUSION: This study provides a significant insight into the understanding of the ex vivo expansion of canine T cells in adoptive immunotherapy.


Assuntos
Técnicas de Cultura de Células , Imunoterapia Adotiva , Receptores de Antígenos de Linfócitos T , Linfócitos T , Animais , Antígenos CD20/genética , Linhagem Celular Tumoral , Cães , Imunoterapia Adotiva/veterinária , Linfoma de Células B/terapia , Linfoma de Células B/veterinária , Receptores de Antígenos de Linfócitos T/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA